InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc. (INM) — Form 424B3: Prospectus
About this filing
InMed Pharmaceuticals Inc. (INM) filed Form 424B3 (prospectus) with the SEC on Oct 28, 2026.
Key facts
- Document
- 424B3
More INM filings
- 8-K
Filed Nov 5, 2026
- 8-K
Filed Nov 5, 2026
- 8-K
Filed Nov 3, 2026
- 10-Q
Filed Nov 2, 2026
- 425
Filed Nov 2, 2026
- 4
Filed Oct 27, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.